Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of substitutes
• Threat of new entrants
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY PROCEDURE TYPE
• Overview
• Comparison by procedure type
• Body contouring
• Botox
• Dermal fillers
• Dental implants
• Skin resurfacing
• Saline breast implant
• Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Medical aesthetics market in Americas
• Medical aesthetics market in EMEA
• Medical aesthetics market in APAC
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Advances in technology
• Growing focus on promotional activities
• Increased focus on fat reduction procedures
• Growing medical tourism

PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Allergan
• Dentsply Sirona
• Galderma
• Johnson & Johnson
• Merz Pharma
• Valeant Pharmaceuticals
• Other prominent vendors

PART 15: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Related market: Global medical devices market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition: Inclusions and exclusions checklist
Exhibit 05: Global medical aesthetics market: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global medical aesthetics market: 2017-2022 ($ millions)
Exhibit 08: Global medical aesthetics market: Year-over-year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of substitutes
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition: Five forces 2017
Exhibit 17: Market condition: Five forces 2022
Exhibit 18: Global medical aesthetic market: Segmentation by procedure type 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global body contouring market 2017-2022 ($ millions)
Exhibit 21: Global body contouring market: Year-over-year growth 2018-2022 (%)
Exhibit 22: Global Botox market 2017-2022 ($ millions)
Exhibit 23: Global Botox market: Year-over-year growth 2018-2022 (%)
Exhibit 24: Global dermal fillers market 2017-2022 ($ millions)
Exhibit 25: Global dermal fillers market: Year-over-year growth 2018-2022 (%)
Exhibit 26: Global dental implants market 2017-2022 ($ millions)
Exhibit 27: Global dental implants market: Year-over-year growth 2018-2022 (%)
Exhibit 28: Global skin resurfacing market 2017-2022 ($ millions)
Exhibit 29: Global skin resurfacing market: Year-over-year growth 2018-2022 (%)
Exhibit 30: Global saline breast implant market 2017-2022 ($ millions)
Exhibit 31: Global saline breast implant market: Year-over-year growth 2018-2022 (%)
Exhibit 32: Market opportunity by product
Exhibit 33: Customer landscape
Exhibit 34: Global medical aesthetics market: Segmentation by geography 2017-2022 (% share)
Exhibit 35: Regional comparison
Exhibit 36: Medical aesthetics market in Americas 2017-2022 ($ millions)
Exhibit 37: Medical aesthetics market in Americas: Year-over-year growth 2018-2022 (%)
Exhibit 38: Top three countries in Americas
Exhibit 39: Medical aesthetics market in EMEA 2017-2022 ($ millions)
Exhibit 40: Medical aesthetics market in EMEA: Year-over-year growth 2018-2022 (%)
Exhibit 41: Top three countries in EMEA
Exhibit 42: Medical aesthetics market in APAC 2017-2022 ($ millions)
Exhibit 43: Medical aesthetics market in APAC: Year-over-year growth 2018-2022 (%)
Exhibit 44: Top three countries in APAC
Exhibit 45: Market opportunity
Exhibit 46: Increase in geriatric population 2010-2016 (%)
Exhibit 47: Cost of key medical aesthetic products
Exhibit 48: Digital engagement of key vendors
Exhibit 49: Vendor landscape
Exhibit 50: Landscape disruption
Exhibit 51: Vendors covered
Exhibit 52: Vendor classification
Exhibit 53: Market positioning of vendors
Exhibit 54: Allergan: Overview
Exhibit 55: Allergan: Business segments
Exhibit 56: Allergan: Organizational developments
Exhibit 57: Allergan: Geographic focus
Exhibit 58: Allergan: Segment focus
Exhibit 59: Allergan: Key offerings
Exhibit 60: Dentsply Sirona: Overview
Exhibit 61: Dentsply Sirona: Business segments
Exhibit 62: Dentsply Sirona: Organizational developments
Exhibit 63: Dentsply Sirona: Geographic focus
Exhibit 64: Dentsply Sirona: Segment focus
Exhibit 65: Dentsply Sirona: Key offerings
Exhibit 66: Galderma: Overview
Exhibit 67: Galderma: Business segments
Exhibit 68: Galderma: Organizational developments
Exhibit 69: Galderma: Geographic focus
Exhibit 70: Galderma: Segment focus
Exhibit 71: Galderma: Key offerings
Exhibit 72: Johnson & Johnson: Overview
Exhibit 73: Johnson & Johnson: Business segments
Exhibit 74: Johnson & Johnson: Organizational developments
Exhibit 75: Johnson & Johnson: Geographic focus
Exhibit 76: Johnson & Johnson: Segment focus
Exhibit 77: Johnson & Johnson: Key offerings
Exhibit 78: Merz Pharma: Overview
Exhibit 79: Merz Pharma: Business segments
Exhibit 80: Merz Pharma: Organizational developments
Exhibit 81: Merz Pharma: Geographic focus
Exhibit 82: Merz Pharma: Segment focus
Exhibit 83: Merz Pharma: Key offerings
Exhibit 84: Valeant Pharmaceuticals: Overview
Exhibit 85: Valeant Pharmaceuticals: Business segments
Exhibit 86: Valeant Pharmaceuticals: Organizational developments
Exhibit 87: Valeant Pharmaceuticals: Geographic focus
Exhibit 88: Valeant Pharmaceuticals: Segment focus
Exhibit 89: Valeant Pharmaceuticals: Key offerings